Category: Press Release

Under this license and collaboration agreement, EVOQ and Amgen will work on discovery and development of drugs for autoimmune disorders.

Researchers from the University of Michigan and the University of Maryland were awarded a $5 million grant to establish a new Center for Research on Complex Generics. BI Faculty Professor Anna Schwendeman will be the center co-director along with Professor James Polli from the University of Maryland.

The center is funded by the FDA Office of Generic Drugs and aims at bringing complex generic drugs and drug products to market faster.

In work started during his time at Rice University, Deepak Nagrath continues to research cancer cell metabolism and how cancer cells interact. Learning how the cells communicate could lead to new targets for more effective treatments than those currently is use.

Currently being used in a breast cancer clinical trial to isolate cancer cells in blood, Sunitha Nagrath and Max Wicha led the development of a hydrodynamic maze called the labyrinth chip. With its innovative design, the labyrinth chip allows researchers to capture cells for molecular analysis so they can know what to target with treatments.

BI director, Joerg Lahann, is part of the U-M team for the newly announced NSF Engineering Research Center (ERC). Led by Boston University, the NSF-ERC aims to grow new heart tissues. For more details on the award and team, please visit here.

Peter Tessier has joined UM from the Rensselaer Polytechnic Institute. He was named the Albert M. Mattocks Professor of Pharmaceutial Sciences and a Professor of Chemical Engineering. Welcome Peter!

Anna Schwendeman and James Moon recently published an article in Nature Materials reporting their work on designing nanodiscs for delivery of cancer therapies.

More details can be found in the article and the press release.

Sunitha Nagrath was promoted to Associate Professor with tenure in the Department of Chemical Engineering. Congratulations, Sunitha!